Analysts: Herbalife Will Keep Up Double-Digit Revenue and 3 More Research Notes to Explore

Herbalife (NYSE:HLF): Canaccord has raised its Herbalife estimates following a significant second-quarter beat and guidance, and continues to expect Herbalife to report double-digit revenue and earnings growth driven by business efficiencies and daily consumption model. It rates the shares at Buy.

HLF (NASDAQ:PCLN): Piper Jaffray expects to report solid second-quarter results on August 8. Its evidence suggests that the company is continuing to gain market share. The firm has upped its price target for shares to $1,034 from $850 and keeps an Overweight rating on the stock.


Teva Pharmaceuticals (NYSE:TEVA): Goldman Sachs has downgraded Teva to Sell from Neutral based on relative valuation and increasing pressure from an accelerated generic Copaxone timeline. The firm has also dropped its price target to $40 from $41.


Spirit Airlines (NASDAQ:SAVE): Citigroup has downgraded Spirit Airlines to Neutral from Buy, citing overhang risk from Indigo Partners and its affiliates’ plan to sell all of their remaining shares in the carrier. The firm has lowered its price target for shares to $37 from $41.


Don’t Miss: History and Warren Buffett Say Cash Is a Terrible Investment.